Companies: 10,795·Total market cap: $144.5T
GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGSNASDAQHealthcare● Active
$51.80
$-0.41(-0.79%)
Market Cap$1.5B
P/E Ratio
52W High$170.87
52W Low$32.21
Overview

GeneDx Holdings Corp. (WGS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · WGS · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.66wgs eps ttm · wgs earnings per shareEarnings history
PE Ratio (TTM)wgs pe ratio ttm · wgs price to earningsPE Ratio deep dive
Revenue (TTM)$442.7Mwgs revenue ttm · wgs annual revenueFull revenue history
Dividend YieldNo Dividenddoes wgs pay dividends · wgs dividend yieldDividend history
Shares Outstanding26.9Mwgs shares outstanding · wgs floatShares outstanding history
Next EarningsAug 4, 2026Est.wgs earnings date · wgs next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$427.5M▲ +39.97% YoY
202320242025
genedx holdings corp. revenue · wgs revenue 2025
FY 2025Net Income-$21.0M▲ +59.80% YoY
202320242025
genedx holdings corp. net income · wgs profit 2025
FY 2025EPS$-0.73▲ +62.37% YoY
202320242025
wgs eps · genedx holdings corp. earnings per share 2025
TTM:Revenue: $442.7MNet Income: -$77.8MEPS: $-2.66View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis wgs a buy · wgs analyst rating
Strong Buy
0
Buy
10
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$70.00Low
$51.80Current
$96.43Avg Target86.16% upside
$150.00High
wgs price target · wgs 12 month forecast

Total: 11 · Buy rate: 90.9%

The WGS analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $96.43, representing +86.16% upside from the current price of $51.80.

Stock Performance

Full History
1D-0.79%
1W-4.07%
1M+27.05%
3M-45.19%
YTD-60.17%
1Y-28.47%
5Y-87.44%

About GeneDx Holdings Corp.

CEOKatherine A. Stueland
IPO DateNov 4, 2020
Employees1,000
CountryUS
Websitegenedx.com

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence a…

what is genedx holdings corp. · wgs stock overview · genedx holdings corp. company profile · who is genedx holdings corp. ceo · wgs NASDAQ · genedx holdings corp. headquarters · genedx holdings corp. business segments

About Stock Overview & Key Data

GeneDx Holdings Corp. (WGS) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Nov 4, 2020. As of the latest trading session, WGS stock price is $51.80, with a market capitalization of $1.5B. The stock has returned -28.47% over the past 12 months and -60.17% year-to-date.

According to 11 Wall Street analysts, the consensus rating for GeneDx Holdings Corp. stock is Buy, with an average 12-month price target of $96.43. In fiscal year 2025, GeneDx Holdings Corp. reported revenue of $427.5M and net income of -$21.0M. For detailed data — including GeneDx Holdings Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, GeneDx Holdings Corp. (WGS) stock price is $51.80. The stock is traded on NASDAQ under the ticker symbol WGS. The 52-week range is $32.21 – $170.87.

WGS stock priceWGS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice